michigan glp-1 nausea lawsuit FDA warns Ozempic and Wegovy maker over unreported side effects GLP-1s linked to smell and

Whether GLP1-RA improve or worsen eating disorders is an important clinical question

For example, overweight and obese T2D patients treated with activin type 2 receptor antagonist bimagrumab in a phase 2 trial achieved net weight loss, comprising significant loss of total body fat mass while gaining some lean mass (i.e

Diverticulitis is caused by infected pouch-like structures that form in the wall of the large intestine, also known as diverticulosis

Key Takeaways On April 1, 2026, FDA issued astatementreminding 503A pharmacies and 503B outsourcing facilities that compounded drugs qualify for the statutory exemptions under the Federal Food, Drug, and Cosmetic Act (FD&C Act), only when applicable conditions are satisfied, with specific focus on the essentially a copy standard.

Euglycemic diabetic ketoacidosis (EDKA) is a rare but potentially life-threatening condition that presents with metabolic acidosis and ketonemia in the absence of hyperglycemia

But Big Food isnt happy